{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T08:40:17Z","timestamp":1741941617904,"version":"3.38.0"},"posted":{"date-parts":[[2025,1,8]]},"group-title":"In Review","reference-count":13,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,12,31]]},"abstract":"<title>Abstract<\/title>\n        <p><bold>Background<\/bold>\nPatients\u2019 preferences are crucial to formulating personalized treatment plans. We developed a self-reported questionnaire, Therapy Preference Scale (TPS), to examine treatment preferences of patients with cancer.\n<bold>Methods<\/bold>\nTPS has 30 questions-19 on patients' preferences on safety, quality of life, and treatment effectiveness, 8 questions on importance of various treatment characteristics, and 3 on patients' preferred intent of therapy, expenses, and life expectancy gain. We recruited 300 adults&gt;18 years with a cancer diagnosis and categorized them into 4 age-by-sex groups (younger men&lt;60 years, older men\u226560 years, younger women&lt;60 years, older women\u226560 years). Kruskal-Wallis non-parametric ANOVA method was used to compare responses among 4 groups.\n<bold>Results<\/bold>\nOlder women, compared to other groups, were more likely to value maintenance of cognitive function and ability to perform daily activities. Older women were more likely to risk having a shorter life expectancy rather than facing the risk of long-term cognitive impairments. Younger men and women were more likely to accept more effective treatment, even if it caused significant pain. A higher percentage of younger men, compared to other groups, valued maintaining sex life. Older men and women were more likely to prefer oral pills over intravenous therapy.\n<bold>Conclusion<\/bold>\nPatient preferences may vary based on age and sex with older women prioritizing cognitive and physical function independence more frequently, whereas younger men and women willing to pursue more effective treatment options even with a greater risk of significant pain. TPS can elicit detailed preferences of an individual patient to facilitate shared decision-making with their oncologists.<\/p>","DOI":"10.21203\/rs.3.rs-5743881\/v1","type":"posted-content","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T10:41:47Z","timestamp":1736332907000},"source":"Crossref","is-referenced-by-count":0,"title":["Age and Sex-Based Differences in Therapy Preferences Among Patients with Cancer: Evidence from\u00a0a Novel Therapy Preference Scale"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2368-1510","authenticated-orcid":false,"given":"Prajwal","family":"Dhakal","sequence":"first","affiliation":[{"name":"The University of Iowa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher S.","family":"Wichman","sequence":"additional","affiliation":[{"name":"University of Nebraska Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bunny J","family":"Pozehl","sequence":"additional","affiliation":[{"name":"University of Nebraska Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radowan","family":"Elnair","sequence":"additional","affiliation":[{"name":"Roger Williams Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amulya","family":"Yellala","sequence":"additional","affiliation":[{"name":"University of Nebraska Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalika","family":"Mahato","sequence":"additional","affiliation":[{"name":"University of Nebraska Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijaya Raj","family":"Bhatt","sequence":"additional","affiliation":[{"name":"University of Nebraska Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"year":"2016","author":"Hamelinck VC","key":"ref1","unstructured":"Hamelinck VC, Bastiaannet E, Pieterse AH et al (2016) A Prospective Comparison of Younger and Older Patients' Preferences for Adjuvant Chemotherapy and Hormonal Therapy in Early Breast Cancer. Clinical Breast Cancer. 2016\/10\/01\/;16(5):379\u2013388"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jgo.2018.11.005","article-title":"Understanding patients' values and priorities in selecting cancer treatments: Developing a therapy preference scale","volume":"10","author":"Bhatt VR","year":"2019","unstructured":"Bhatt VR (2019) Understanding patients' values and priorities in selecting cancer treatments: Developing a therapy preference scale. J Geriatr Oncol 10(5):677\u2013679","journal-title":"J Geriatr Oncol"},{"issue":"3","key":"ref3","first-page":"311","article-title":"Preferences of adults with cancer for systemic cancer treatment: do preferences differ based on age? Future Oncology","volume":"18","author":"Dhakal P","unstructured":"Dhakal P, Wichman CS, Pozehl B et al Preferences of adults with cancer for systemic cancer treatment: do preferences differ based on age? Future Oncology. 2021 2022\/01\/01;18(3):311\u2013321"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e24186","DOI":"10.1200\/JCO.2020.38.15_suppl.e24186","article-title":"Understanding therapy preferences of cancer patients with the use of therapy preference scale","author":"Dhakal P","year":"2020","unstructured":"Dhakal P, Wichman CS, Pozehl BJ et al (2020) Understanding therapy preferences of cancer patients with the use of therapy preference scale. J Clin Oncol. 2020\/05\/20;38(15_suppl):e24186\u2013e24186","journal-title":"J Clin Oncol"},{"issue":"01","key":"ref5","first-page":"37","article-title":"Development and validation of the Therapy Preference Scale to understand patients\u00b4 systemic cancer treatment preferences","volume":"17","author":"Bhatt VR","unstructured":"Bhatt VR, Dhakal P, Wichman CS et al Development and validation of the Therapy Preference Scale to understand patients\u00b4 systemic cancer treatment preferences. Future Oncol 2020 2021\/01\/ 01;17(1):37\u201344","journal-title":"Future Oncol 2020 2021\/01\/"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/07481180126202","volume":"25","author":"Bookwala KMCAFPHDJHDWDSJ","unstructured":"Bookwala KMCAFPHDJHDWDSJ, GENDER, DIFFERENCES IN OLDER ADULTS' PREFERENCES FOR LIFE-SUSTAINING MEDICAL TREATMENTS AND END-OF-LIFE VALUES. Death Stud. 2001 2001\/03\/01;25(2):127\u2013149","journal-title":"Death Stud"},{"issue":"1","key":"ref7","first-page":"1","article-title":"Preference for Palliative Care in Cancer Patients: Are Men and Women Alike? Journal of Pain and Symptom Management. 2018 2018\/07\/01\/;","volume":"56","author":"Saeed F","unstructured":"Saeed F, Hoerger M, Norton SA et al Preference for Palliative Care in Cancer Patients: Are Men and Women Alike? Journal of Pain and Symptom Management. 2018 2018\/07\/01\/;56(1):1\u20136e1"},{"issue":"16","key":"ref8","first-page":"2814","article-title":"Male-female patient differences in the association between end-of-life discussions and receipt of intensive","volume":"121","author":"Sharma RK","year":"2015","unstructured":"Sharma RK, Prigerson HG, Penedo FJ et al (2015) Male-female patient differences in the association between end-of-life discussions and receipt of intensive. 121(16):2814\u20132820 2015\/08\/15;. care near death [https:\/\/doi.org\/10.1002\/cncr.29417]. Cancer"},{"issue":"23","key":"ref9","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1002\/cncr.28940","article-title":"Patient preferences in advanced or recurrent ovarian cancer","volume":"120","author":"Havrilesky LJ","year":"2014","unstructured":"Havrilesky LJ, Alvarez Secord A, Ehrisman JA et al (2014) Patient preferences in advanced or recurrent ovarian cancer. Cancer 120(23):3651\u20133659","journal-title":"Cancer"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10549-013-2727-3","article-title":"Preference weights for chemotherapy side effects from the perspective of women with breast cancer","volume":"2013\/11\/01","author":"Kuchuk I","year":"2013","unstructured":"Kuchuk I, Bouganim N, Beusterien K et al (2013) Preference weights for chemotherapy side effects from the perspective of women with breast cancer. Breast Cancer Res Treat 2013\/11\/01(1):101\u2013107","journal-title":"Breast Cancer Res Treat"},{"article-title":"Patient Preferences Regarding Chemotherapy in Metastatic Breast Cancer\u2014A Conjoint Analysis for Common Taxanes [Original Research]","author":"Spaich S","key":"ref11","unstructured":"Spaich S, Kinder J, Hetjens S et al Patient Preferences Regarding Chemotherapy in Metastatic Breast Cancer\u2014A Conjoint Analysis for Common Taxanes [Original Research]. Frontiers in Oncology. 2018 2018-November-21;8(535)."},{"issue":"14","key":"ref12","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1056\/NEJMsa012528","article-title":"Understanding the Treatment Preferences of Seriously Ill Patients","volume":"346","author":"Fried TR","year":"2002","unstructured":"Fried TR, Bradley EH, Towle VR et al (2002) Understanding the Treatment Preferences of Seriously Ill Patients. N Engl J Med 346(14):1061\u20131066","journal-title":"N Engl J Med"},{"issue":"36(15_suppl","key":"ref13","doi-asserted-by":"crossref","first-page":"10009","DOI":"10.1200\/JCO.2018.36.15_suppl.10009","article-title":"Patient-defined goals and preferences among older adults with cancer starting chemotherapy (CT)","author":"Soto Perez E","year":"2018","unstructured":"De Soto Perez E, Li D, Sun C-L et al (2018) Patient-defined goals and preferences among older adults with cancer starting chemotherapy (CT). J Clin Oncol. 2018\/05\/20;36(15_suppl):10009\u201310009","journal-title":"J Clin Oncol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5743881\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5743881\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T07:47:02Z","timestamp":1741938422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5743881\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":13,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-5743881\/v1","relation":{},"subject":[],"published":{"date-parts":[[2025,1,8]]},"subtype":"preprint"}}